John Wiley & Sons
The 10-second takeaway
For the quarter ended Jan. 31 (Q3), John Wiley & Sons beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded. Non-GAAP earnings per share expanded slightly. GAAP earnings per share contracted.
Gross margins grew, operating margins increased, net margins contracted.
John Wiley & Sons logged revenue of $472.4 million. The two analysts polled by S&P Capital IQ anticipated revenue of $455.9 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.93. The two earnings estimates compiled by S&P Capital IQ predicted $0.83 per share. Non-GAAP EPS of $0.93 for Q3 were 2.2% higher than the prior-year quarter's $0.91 per share. GAAP EPS of $0.95 for Q3 were 7.8% lower than the prior-year quarter's $1.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 70.0%, 150 basis points better than the prior-year quarter. Operating margin was 17.7%, 30 basis points better than the prior-year quarter. Net margin was 12.1%, 180 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $465.0 million. On the bottom line, the average EPS estimate is $0.85.
Next year's average estimate for revenue is $1.76 billion. The average EPS estimate is $2.98.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on John Wiley & Sons is outperform, with an average price target of $47.67.
Can your portfolio provide you with enough income to last through retirement? You'll need more than John Wiley & Sons. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add John Wiley & Sons to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Healthcare: Is Celgene Going to Buy Juno Therapeutics?
A big biotech merger could be in the works.
American Express Earnings Beat Estimates, but It's Not All Good News
Earnings and revenue both surpassed expectations, but the company's tax reform charge and plans to recapitalize are disappointing investors.
What Happened in the Stock Market Today
On a day the indexes pulled back from recent record highs, Wyndham announced it is buying La Quinta, and Alcoa reported disappointing profits.